BERT-1
Beta Energy Restenosis Trial- 1


Purpose
To evaluate the feasibility of endovascular irradiation using the Beta-Cath System in human coronary arteries, to confirm the operational specifications of the device, to examine the effect of 3 different doses of radiation (12, 14, and 16 Gy at 2 mm), and to observe the restenosis parameters compared to a historic control group.

References
The trial design has not been published

Voltar

Apoio: Libbs Farmacêutica Farmacêutica